Cargando…
Pharmacoepidemiology for nephrologists: do proton pump inhibitors cause chronic kidney disease?
Pharmacoepidemiology studies are increasingly used for research into safe prescribing in chronic kidney disease (CKD). Typically, patients prescribed a drug are compared with patients who are not on the drug and outcomes are compared to draw conclusions about the drug effects. This review article ai...
Autores principales: | Tomlinson, Laurie A., Fogarty, Damian G., Douglas, Ian, Nitsch, Dorothea |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5837711/ https://www.ncbi.nlm.nih.gov/pubmed/28201528 http://dx.doi.org/10.1093/ndt/gfw349 |
Ejemplares similares
-
Proton Pump Inhibitors and Kidney Disease—GI Upset for the Nephrologist?
por: Toth-Manikowski, Stephanie M., et al.
Publicado: (2017) -
Pharmacoepidemiology for nephrologists (part 2): potential biases and how to overcome them
por: Fu, Edouard L, et al.
Publicado: (2020) -
Pharmacoepidemiology for nephrologists (part 1): concept, applications and considerations for study design
por: Trevisan, Marco, et al.
Publicado: (2020) -
The Proton Pump Inhibitor Omeprazole Does Not Promote Clostridioides difficile Colonization in a Murine Model
por: Tomkovich, Sarah, et al.
Publicado: (2019) -
Proton pump inhibitor-induced Sweet’s syndrome: report of acute febrile neutrophilic dermatosis in a woman with recurrent breast cancer
por: Cohen, Philip R.
Publicado: (2015)